Nathan Hardy

Nathan Hardy

Former Executive Vice President, Chief Financial OfficeratSana Biotechnology· In proxies 2023–2024

Pay in FY2024+157% from the year before · Sana Biotechnology stock -60.0% the same year

Nathan Hardy was paid $3.1M in FY2024 (Dec), up 157%. Sana Biotechnology stock fell 60.0% that year.

Pay$100 in the stock at the end of FY22 → $41
Pay is from the Summary Compensation Table of each Sana Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sana BiotechnologyPublic company · 3 yr
    • Former Executive Vice President, Chief Financial Officer2023 – Present · 3 yrStock in role -18%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?